We used activator of PPP to intervene in this pathological process and found that levels of ANA and ADA were increased compared with control, and inflammatory cell infiltration in kidney was more obvious, indicating deteriorating SLE development. The gene discussed is BTG3; the disease is systemic lupus erythematosus.